SIGN UP
LOG IN
G
GCTK
Glucotrack
6.62
0.09+1.38%After Hours: 6.55 -0.07 -1.06%16:53 07/03 EDT
OPEN/PREV CLOSE6.51/6.53
TODAY RANGE6.30-7.38
VOL249.49K
MARKET CAP3.59M
52 WEEK RANGE5.16-3,756.00
AVG VOL (3M)586.43K
% TURNOVER46.00%
TURNOVER--
P/E (TTM)-0.0020
% RANGE16.51%
EPS(TTM)-3,287.3996
P/E(FORWARD)--
P/B0.3890
BVPS17.02
DIVIDEND--
P/S384.62
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.26M
SHARES OUTSTANDING542.36K
NEXT EARNINGS--
FREE FLOAT492.46K
LOT SIZE1
EX-DATE06/16/2025
News
Press Releases
Financial Reports
Profile
Benzinga·06/27 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·06/27 12:07
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·06/26 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga·06/26 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·06/26 12:08
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·06/26 09:12
Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Benzinga·06/25 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
TipRanks·06/25 17:00
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Benzinga·06/25 14:40
Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?
TipRanks·06/25 13:45
GlucoTrack Inc trading resumes
TipRanks·06/25 13:39
GlucoTrack Stock (GCTK) Stock Rockets 130% on Diabetes Tracking Data
TipRanks·06/25 13:35
GlucoTrack Inc trading halted, volatility trading pause
TipRanks·06/25 13:19
GlucoTrack Announces Positive Clinical Study Results
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.